The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator’s risk-based inspection programs.
The first Quality Culture Metrics survey is open to all PDA members with a background or interest in pharmaceutical quality. PDA is sending a link to the survey to selected members based on this criteria. On September 6, a second Quality Culture Metrics Survey will be launched with controlled participation limited to three or four executives at selected companies. The surveys will be open for participation until October 2, 2014.
“PDA is excited to launch the Quality Culture Metrics surveys, the second leg of our ongoing pharmaceutical metrics program,” said PDA President Richard Johnson. “The volunteer PDA Quality Metrics Task Force put together a points to consider document on quality metrics in the first leg, and will initiate the third leg with a conference on pharmaceutical quality metrics later this year.”
PDA is conducting the 2014 PDA Quality Culture Metrics Survey to understand to what degree PDA members’ companies are measuring quality culture and to identify attributes of quality culture appropriate for use as metrics. Respondents are encouraged to base their answers on tools and approaches used at their local work site or facility.
Results will be presented at the 2014 PDA Pharmaceutical Quality Metrics Conference on December 4, 2014 in Washington, DC.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide.
SOURCE Parenteral Drug Association
